Alembic Pharmaceuticals has announced a change in the email address for their Registrar and Share Transfer Agent (RTA), MUFG Intime India Private Limited (MIIPL). Effective October 1, 2025, the new generic email ID for investors will be [email protected]. This change applies to all companies serviced by MIIPL.
Email Update for Investor Communications
Alembic Pharmaceuticals informs stakeholders of a change regarding communications with its Registrar and Share Transfer Agent (RTA), MUFG Intime India Private Limited (MIIPL).
New Contact Information Effective October 1, 2025
Effective October 1, 2025, MIIPL has introduced a new generic email ID for investor-related inquiries. The new email address is [email protected]. This email address will now be the primary point of contact for all investors across various companies managed by MIIPL for share transfer and related processes.
Purpose of the Change
This change aims to streamline investor communications and ensure consistency across all companies serviced by MIIPL. Investors are requested to update their records with the new email address for future correspondence.
Source: BSE
